PW MEDTECH (01358): voluntarily terminates Sichuan Rejian Medical from listing on the Beijing Stock Exchange.
Puhua and Shun (01358) announced on March 11, 2026, after careful analysis of their own business development direction, current market environment, and other key factors, and after thorough research, consultation, and communication with the sponsoring institution, Sichuan Ruijian Medical has decided to adjust their capital market strategic plan and actively terminate their application for listing.
PW MEDTECH (01358) announced that on March 11, 2026, based on a thorough analysis of its own business development direction and key factors in the current market environment, after careful study, full demonstration, and in-depth communication with the sponsor institution, Sichuan Ruijian Medical has decided to adjust its capital market strategic planning and actively terminate its application for listing.
Related Articles

YIDU TECH (02158) inventory share climbed to 4.1%, becoming the benchmark for technology stocks in the Hong Kong stock buyback market.

On March 12, IFBH (06603) spent HK$593,000 to repurchase 50,000 shares.

MOST KWAI CHUNG (01716) change of ownership, acquired by Legend Holdings Limited at a discount of approximately 42.45%, and will resume trading on March 13th.
YIDU TECH (02158) inventory share climbed to 4.1%, becoming the benchmark for technology stocks in the Hong Kong stock buyback market.

On March 12, IFBH (06603) spent HK$593,000 to repurchase 50,000 shares.

MOST KWAI CHUNG (01716) change of ownership, acquired by Legend Holdings Limited at a discount of approximately 42.45%, and will resume trading on March 13th.

RECOMMEND

“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026

Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026

U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026


